BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22516133)

  • 1. Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem.
    Coyle PV; McCaughey C; Nager A; McKenna J; O'Neill H; Feeney SA; Fairley D; Watt A; Cox C; Curran T
    J Med Microbiol; 2012 Jul; 61(Pt 7):1009-1015. PubMed ID: 22516133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumocystis jirovecii multilocus genotyping profiles in Northern Ireland.
    Curran T; McCaughey C; Coyle PV
    J Med Microbiol; 2013 Aug; 62(Pt 8):1170-1174. PubMed ID: 23699069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned from a pneumocystis pneumonia outbreak at a Scottish renal transplant centre.
    McClarey A; Phelan P; O'Shea D; Henderson L; Gunson R; Laurenson IF
    J Hosp Infect; 2019 Jul; 102(3):311-316. PubMed ID: 30802526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pneumocystis jirovecii pneumonia outbreak in a single kidney-transplant center: role of cytomegalovirus co-infection.
    Pliquett RU; Asbe-Vollkopf A; Hauser PM; Presti LL; Hunfeld KP; Berger A; Scheuermann EH; Jung O; Geiger H; Hauser IA
    Eur J Clin Microbiol Infect Dis; 2012 Sep; 31(9):2429-37. PubMed ID: 22402816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients.
    Korkmaz Ekren P; Töreyin ZN; Nahid P; Doskaya M; Caner A; Turgay N; Zeytinoglu A; Toz S; Bacakoglu F; Guruz Y; Erensoy S
    Clin Respir J; 2018 Nov; 12(11):2590-2597. PubMed ID: 30244544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of positive
    Lee HY; Kang HS; Lee HY; Rhee CK; Lee SY; Kim SC; Kim SJ; Park YJ; Kim YK; Kang JY
    Korean J Intern Med; 2017 May; 32(3):478-485. PubMed ID: 27951623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumocystis jirovecii pneumonia in patients with end-stage renal disease: a comparison with the general population.
    Leth S; Jensen-Fangel S; Østergaard L; Rostved AA; Jespersen B; Søgaard OS
    Scand J Infect Dis; 2014 Oct; 46(10):704-11. PubMed ID: 25131415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children <5 years of age admitted to hospital with clinical severe pneumonia.
    Lanaspa M; O'Callaghan-Gordo C; Machevo S; Madrid L; Nhampossa T; Acácio S; de la Horra C; Friaza V; Campano E; Alonso PL; Calderón EJ; Roca A; Bassat Q
    Clin Microbiol Infect; 2015 Nov; 21(11):1018.e9-1018.e15. PubMed ID: 26231980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients].
    Özkoç S; Bayram Delibaş S
    Mikrobiyol Bul; 2015 Apr; 49(2):221-30. PubMed ID: 26167822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients.
    Gianella S; Haeberli L; Joos B; Ledergerber B; Wüthrich RP; Weber R; Kuster H; Hauser PM; Fehr T; Mueller NJ
    Transpl Infect Dis; 2010 Feb; 12(1):1-10. PubMed ID: 19744285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Pneumocystis jirovecii pneumonia (2010-2013): the first Croatian report.
    Babic-Erceg A; Vilibic-Cavlek T; Erceg M; Mlinaric-Missoni E; Begovac J
    Acta Microbiol Immunol Hung; 2014 Jun; 61(2):181-8. PubMed ID: 24939686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
    Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
    Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of outbreaks of Pneumocystis jirovecii pneumonia: evidence that P. jirovecii is a transmissible organism and the implications for healthcare infection control.
    Yiannakis EP; Boswell TC
    J Hosp Infect; 2016 May; 93(1):1-8. PubMed ID: 26996089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiologic analysis of a Pneumocystis pneumonia outbreak among renal transplant patients.
    Urabe N; Ishii Y; Hyodo Y; Aoki K; Yoshizawa S; Saga T; Murayama SY; Sakai K; Homma S; Tateda K
    Clin Microbiol Infect; 2016 Apr; 22(4):365-371. PubMed ID: 26724988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure.
    Choi JS; Lee SH; Leem AY; Song JH; Kim SY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
    PLoS One; 2018; 13(10):e0206231. PubMed ID: 30359436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Induced sputum to determine the prevalence of Pneumocystis jirovecii in immunocompromised children with pneumonia.
    Das CK; Mirdha BR; Singh S; Seth R; Bagga A; Lodha R; Kabra SK
    J Trop Pediatr; 2014 Jun; 60(3):216-22. PubMed ID: 24425204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiologic Trends and Clinical Features of Pneumocystis jirovecii Pneumonia in Non-HIV Patients in a Tertiary-Care Hospital in Korea over a 15-Year-Period.
    Lee HY; Choi SH; Kim T; Chang J; Kim SH; Lee SO; Kim MN; Sung H
    Jpn J Infect Dis; 2019 Jul; 72(4):270-273. PubMed ID: 30918147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics of hospital-onset Pneumocystis pneumonia and genotypes of Pneumocystis jirovecii in a single tertiary centre in Korea.
    Kim T; Lee SO; Hong HL; Lee JY; Kim SH; Choi SH; Kim MN; Kim YS; Woo JH; Sung H
    BMC Infect Dis; 2015 Feb; 15():102. PubMed ID: 25884420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumocystis jirovecii pneumonia in patients with and without human immunodeficiency virus infection.
    Su YS; Lu JJ; Perng CL; Chang FY
    J Microbiol Immunol Infect; 2008 Dec; 41(6):478-82. PubMed ID: 19255691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients.
    Cordonnier C; Cesaro S; Maschmeyer G; Einsele H; Donnelly JP; Alanio A; Hauser PM; Lagrou K; Melchers WJ; Helweg-Larsen J; Matos O; Bretagne S; Maertens J;
    J Antimicrob Chemother; 2016 Sep; 71(9):2379-85. PubMed ID: 27550990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.